应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
NVAX 诺瓦瓦克斯医药
交易中 03-28 14:06:35 EDT
4.77
-0.08
-1.65%
最高
4.95
最低
4.77
成交量
174.31万
今开
4.84
昨收
4.85
日振幅
3.61%
总市值
6.68亿
流通市值
5.97亿
总股本
1.40亿
成交额
849.55万
换手率
1.39%
流通股本
1.25亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
BUZZ-生物技术公司因 2024 年收入预期不乐观而下跌
Reuters · 03-20
BUZZ-生物技术公司因 2024 年收入预期不乐观而下跌
诺瓦瓦克斯医药盘中异动 早盘股价大跌5.16%报4.69美元
自选股智能写手 · 03-20
诺瓦瓦克斯医药盘中异动 早盘股价大跌5.16%报4.69美元
诺瓦瓦克斯医药盘中异动 股价大涨5.02%
自选股智能写手 · 03-16
诺瓦瓦克斯医药盘中异动 股价大涨5.02%
诺瓦瓦克斯医药盘中异动 下午盘快速下跌5.14%
自选股智能写手 · 03-15
诺瓦瓦克斯医药盘中异动 下午盘快速下跌5.14%
诺瓦瓦克斯医药盘中异动 下午盘股价大跌5.05%报5.18美元
自选股智能写手 · 03-12
诺瓦瓦克斯医药盘中异动 下午盘股价大跌5.05%报5.18美元
诺瓦瓦克斯医药盘中异动 股价大涨5.17%报5.90美元
自选股智能写手 · 03-08
诺瓦瓦克斯医药盘中异动 股价大涨5.17%报5.90美元
资料盒-美国和加拿大公司以裁员拉开 2024 年的序幕
Reuters · 03-07
资料盒-美国和加拿大公司以裁员拉开 2024 年的序幕
诺瓦瓦克斯医药盘中异动 早盘股价大涨5.10%
自选股智能写手 · 03-05
诺瓦瓦克斯医药盘中异动 早盘股价大涨5.10%
诺瓦瓦克斯医药盘中异动 早盘急速下挫5.01%报5.12美元
自选股智能写手 · 03-04
诺瓦瓦克斯医药盘中异动 早盘急速下挫5.01%报5.12美元
诺瓦瓦克斯医药盘中异动 早盘急速上涨5.26%报5.20美元
自选股智能写手 · 03-01
诺瓦瓦克斯医药盘中异动 早盘急速上涨5.26%报5.20美元
纳斯达克生物科技指数收跌1.48%,成分股诺瓦瓦克斯跌约27%
财通社 · 02-29
纳斯达克生物科技指数收跌1.48%,成分股诺瓦瓦克斯跌约27%
嗡嗡声--美国股票走势-Shift4 Payments、Chart Industries、Applied Therapeutics
Reuters · 02-29
嗡嗡声--美国股票走势-Shift4 Payments、Chart Industries、Applied Therapeutics
诺瓦瓦克斯医药(NVAX)跌近28% 去年Q4营收不及市场预期
金吾财讯 · 02-28
诺瓦瓦克斯医药(NVAX)跌近28% 去年Q4营收不及市场预期
诺瓦瓦克斯医药盘前暴跌逾21% Q4营收不及预期
新浪财经 · 02-28
诺瓦瓦克斯医药盘前暴跌逾21% Q4营收不及预期
诺瓦瓦克斯医药股价重挫25.18% 市值跌1.35亿美元
自选股智能写手 · 02-28
诺瓦瓦克斯医药股价重挫25.18% 市值跌1.35亿美元
资料盒-美国和加拿大公司以裁员拉开 2024 年的序幕
Reuters · 02-28
资料盒-美国和加拿大公司以裁员拉开 2024 年的序幕
BUZZ-Novavax 因第四季度业绩不佳而下跌
Reuters · 02-28
BUZZ-Novavax 因第四季度业绩不佳而下跌
诺瓦瓦克斯医药盘中大跌近30%,Q4营收不及预期
华尔街见闻 · 02-28
诺瓦瓦克斯医药盘中大跌近30%,Q4营收不及预期
诺维信预计 2024 年销售额持平或下降,目标是扩大 COVID 疫苗的市场份额
Reuters · 02-28
诺维信预计 2024 年销售额持平或下降,目标是扩大 COVID 疫苗的市场份额
诺瓦瓦克斯医药盘中异动 急速拉升5.09%报5.78美元
自选股智能写手 · 02-27
诺瓦瓦克斯医药盘中异动 急速拉升5.09%报5.78美元
加载更多
公司概况
公司名称:
诺瓦瓦克斯医药
所属市场:
NASDAQ
上市日期:
--
主营业务:
Novavax, Inc.是一家新型临床阶段生物制药公司,致力于发现、开发和商业化纳米颗粒重组疫苗和佐剂。公司的疫苗技术平台是根据专有纳米疫苗重组技术开发的,包括病毒样颗粒和蛋白质纳米颗粒候选疫苗。公司的候选疫苗是转基因的三维纳米结构,结合了免疫重要蛋白。公司的疫苗产品针对各种传染病,还有目前在临床开发的针对呼吸道合胞体病毒(RSV)、季节性流感和大流行性流感的产品。此外,CPL生物制剂私人有限公司(CPLB),其合资公司在印度,正积极开发一系列疫苗候选产品,是由诺瓦瓦克斯公司转基因完成的。1987年,诺瓦瓦克斯公司在特拉华州的法律下成立。
发行价格:
--
{"stockData":{"symbol":"NVAX","market":"US","secType":"STK","nameCN":"诺瓦瓦克斯医药","latestPrice":4.77,"timestamp":1711649175218,"preClose":4.85,"halted":0,"volume":1743053,"delay":0,"floatShares":125194524,"shares":139953143,"eps":-5.409078,"marketStatus":"交易中","marketStatusCode":2,"change":-0.08,"latestTime":"03-28 14:06:35 EDT","open":4.84,"high":4.945,"low":4.77,"amount":8495509.0701091,"amplitude":0.036082,"askPrice":4.78,"askSize":2857,"bidPrice":4.77,"bidSize":2011,"shortable":3,"etf":0,"ttmEps":-5.409078,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1711656000000},"adr":0,"adjPreClose":4.85,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":4.82,"preClose":4.85,"latestTime":"09:29 EDT","volume":12593,"amount":60619.2691482,"timestamp":1711632548032},"postHourTrading":{"tag":"盘后","latestPrice":4.84,"preClose":4.85,"latestTime":"19:59 EDT","volume":85011,"amount":411823.6666,"timestamp":1711583971321},"volumeRatio":0.632056},"requestUrl":"/m/hq/s/NVAX","defaultTab":"news","newsList":[{"id":"2420001721","title":"BUZZ-生物技术公司因 2024 年收入预期不乐观而下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2420001721","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2420001721?lang=zh_cn&edition=full","pubTime":"2024-03-20 23:19","pubTimestamp":1710947999,"startTime":"0","endTime":"0","summary":" 3月20日 - ** 在美国上市的德国生物技术公司 、 股价下跌6.7%,至87.8美元** BNTX认为 ,其2024年收入介于25亿欧元,31亿欧元低于分析师平均预期 的31.6亿欧元--LSEG** BNTX 第四季度营收为 14.8 亿欧元,低于预期的 18.3 亿欧元。** 其他 COVID-19 疫苗生产商,如 Moderna 股价下跌 2.5%,Novavax 下跌 3.9** 今年以来,BNTX 下跌 17.6%,MRNA 上升 2.8%,NVAX 下跌 ~1 ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2420723537","title":"诺瓦瓦克斯医药盘中异动 早盘股价大跌5.16%报4.69美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2420723537","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2420723537?lang=zh_cn&edition=full","pubTime":"2024-03-20 21:47","pubTimestamp":1710942443,"startTime":"0","endTime":"0","summary":"北京时间2024年03月20日21时47分,诺瓦瓦克斯医药股票出现异动,股价急速下挫5.16%。截至发稿,该股报4.69美元/股,成交量74.6972万股,换手率0.53%,振幅5.47%。诺瓦瓦克斯医药股票所在的生物技术行业中,整体跌幅为0.95%。诺瓦瓦克斯医药公司简介:诺瓦瓦克斯医药公司是一家开发疫苗的生物技术公司。诺瓦瓦克斯与其全资拥有的瑞典子公司合作生产候选疫苗,以应对已知和新出现的疾病威胁。该公司认为,其疫苗技术有可能广泛应用于各种人类传染病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403202147237a4df998&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403202147237a4df998&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419907873","title":"诺瓦瓦克斯医药盘中异动 股价大涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2419907873","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419907873?lang=zh_cn&edition=full","pubTime":"2024-03-16 00:33","pubTimestamp":1710520414,"startTime":"0","endTime":"0","summary":"北京时间2024年03月16日00时33分,诺瓦瓦克斯医药股票出现异动,股价快速上涨5.02%。截至发稿,该股报5.23美元/股,成交量192.199万股,换手率1.37%,振幅6.39%。诺瓦瓦克斯医药股票所在的生物技术行业中,整体跌幅为0.56%。诺瓦瓦克斯医药公司简介:诺瓦瓦克斯医药公司是一家开发疫苗的生物技术公司。诺瓦瓦克斯与其全资拥有的瑞典子公司合作生产候选疫苗,以应对已知和新出现的疾病威胁。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031600333587e7964e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031600333587e7964e&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419980873","title":"诺瓦瓦克斯医药盘中异动 下午盘快速下跌5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2419980873","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419980873?lang=zh_cn&edition=full","pubTime":"2024-03-15 01:01","pubTimestamp":1710435698,"startTime":"0","endTime":"0","summary":"北京时间2024年03月15日01时01分,诺瓦瓦克斯医药股票出现波动,股价大幅跳水5.14%。截至发稿,该股报4.98美元/股,成交量182.511万股,换手率1.30%,振幅5.33%。诺瓦瓦克斯医药股票所在的生物技术行业中,整体跌幅为0.52%。诺瓦瓦克斯医药公司简介:诺瓦瓦克斯医药公司是一家开发疫苗的生物技术公司。诺瓦瓦克斯与其全资拥有的瑞典子公司合作生产候选疫苗,以应对已知和新出现的疾病威胁。该公司认为,其疫苗技术有可能广泛应用于各种人类传染病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403150101387a4cbe6b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403150101387a4cbe6b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2418392225","title":"诺瓦瓦克斯医药盘中异动 下午盘股价大跌5.05%报5.18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2418392225","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2418392225?lang=zh_cn&edition=full","pubTime":"2024-03-12 03:14","pubTimestamp":1710184461,"startTime":"0","endTime":"0","summary":"北京时间2024年03月12日03时14分,诺瓦瓦克斯医药股票出现异动,股价大幅下挫5.05%。截至发稿,该股报5.18美元/股,成交量404.934万股,换手率2.89%,振幅7.98%。机构评级方面,在所有6家参与评级的机构中,50%的券商给予买入建议,17%的券商给予持有建议,33%的券商给予卖出建议。诺瓦瓦克斯医药股票所在的生物技术行业中,整体跌幅为0.19%。诺瓦瓦克斯与其全资拥有的瑞典子公司合作生产候选疫苗,以应对已知和新出现的疾病威胁。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403120314217919653d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403120314217919653d&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2417023050","title":"诺瓦瓦克斯医药盘中异动 股价大涨5.17%报5.90美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2417023050","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2417023050?lang=zh_cn&edition=full","pubTime":"2024-03-08 22:43","pubTimestamp":1709909007,"startTime":"0","endTime":"0","summary":"北京时间2024年03月08日22时43分,诺瓦瓦克斯医药股票出现波动,股价急速拉升5.17%。截至发稿,该股报5.90美元/股,成交量72.1685万股,换手率0.52%,振幅4.63%。机构评级方面,在所有6家参与评级的机构中,50%的券商给予买入建议,17%的券商给予持有建议,33%的券商给予卖出建议。诺瓦瓦克斯医药股票所在的生物技术行业中,整体跌幅为0.46%。诺瓦瓦克斯与其全资拥有的瑞典子公司合作生产候选疫苗,以应对已知和新出现的疾病威胁。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240308224328861dca36&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240308224328861dca36&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2417592547","title":"资料盒-美国和加拿大公司以裁员拉开 2024 年的序幕","url":"https://stock-news.laohu8.com/highlight/detail?id=2417592547","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2417592547?lang=zh_cn&edition=full","pubTime":"2024-03-07 19:21","pubTimestamp":1709810474,"startTime":"0","endTime":"0","summary":" 路透社3月7日 - 2024 年伊始,美国和加拿大各行各业的企业纷纷裁员数千人,这表明随着企业争相控制成本,2023 年出现的裁员潮可能会持续下去。* 加拿大黑莓 计划在上一季度裁员约200人的基础上,再裁员 。* 美国连锁百货公司梅西百货 将裁员2350人, ,关闭五家门店。自然资源* 美国矿业公司 Piedmont Lithium 在削减成本计划中裁减了 27% 的员工。*加拿大油气管道公司TC Energy 已 裁员 ,这是此前宣布的天然气管道部门整合计划的一部分。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2417220410","title":"诺瓦瓦克斯医药盘中异动 早盘股价大涨5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2417220410","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2417220410?lang=zh_cn&edition=full","pubTime":"2024-03-05 22:54","pubTimestamp":1709650448,"startTime":"0","endTime":"0","summary":"北京时间2024年03月05日22时54分,诺瓦瓦克斯医药股票出现波动,股价大幅拉升5.10%。截至发稿,该股报5.77美元/股,成交量128.452万股,换手率0.92%,振幅7.47%。诺瓦瓦克斯医药股票所在的生物技术行业中,整体跌幅为1.05%。诺瓦瓦克斯医药公司简介:Novavax Inc是一家开发疫苗的生物技术公司。Novavax与其全资瑞典子公司合作生产候选疫苗,以应对已知和新出现的疾病威胁。Novavax开发面向普通人群所有年龄人口的候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030522540887e761bb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030522540887e761bb&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2416750128","title":"诺瓦瓦克斯医药盘中异动 早盘急速下挫5.01%报5.12美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2416750128","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2416750128?lang=zh_cn&edition=full","pubTime":"2024-03-04 23:32","pubTimestamp":1709566343,"startTime":"0","endTime":"0","summary":"北京时间2024年03月04日23时32分,诺瓦瓦克斯医药股票出现波动,股价急速跳水5.01%。截至发稿,该股报5.12美元/股,成交量257.037万股,换手率1.84%,振幅8.72%。诺瓦瓦克斯医药股票所在的生物技术行业中,整体跌幅为0.26%。诺瓦瓦克斯医药公司简介:Novavax Inc是一家开发疫苗的生物技术公司。Novavax与其全资瑞典子公司合作生产候选疫苗,以应对已知和新出现的疾病威胁。Novavax开发面向普通人群所有年龄人口的候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403042332237a4953ed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403042332237a4953ed&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2416062817","title":"诺瓦瓦克斯医药盘中异动 早盘急速上涨5.26%报5.20美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2416062817","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2416062817?lang=zh_cn&edition=full","pubTime":"2024-03-01 23:49","pubTimestamp":1709308149,"startTime":"0","endTime":"0","summary":"北京时间2024年03月01日23时49分,诺瓦瓦克斯医药股票出现异动,股价大幅上涨5.26%。截至发稿,该股报5.20美元/股,成交量412.116万股,换手率2.94%,振幅8.31%。诺瓦瓦克斯医药股票所在的生物技术行业中,整体涨幅为2.30%。诺瓦瓦克斯医药公司简介:Novavax Inc是一家开发疫苗的生物技术公司。Novavax与其全资瑞典子公司合作生产候选疫苗,以应对已知和新出现的疾病威胁。Novavax开发面向普通人群所有年龄人口的候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240301234910861da97d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240301234910861da97d&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2415158953","title":"纳斯达克生物科技指数收跌1.48%,成分股诺瓦瓦克斯跌约27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2415158953","media":"财通社","top":-1,"share":"https://www.laohu8.com/m/news/2415158953?lang=zh_cn&edition=full","pubTime":"2024-02-29 05:58","pubTimestamp":1709157480,"startTime":"0","endTime":"0","summary":"成分股中,诺瓦瓦克斯医药收跌26.74%表现最差,该公司四季度营收逊于市场预期;Recursion Pharmaceuticals、Xencor、Denali Therapeutics、Alx Oncology Holdings、Coherus BioSciences、阿卡迪亚跌16.62%-9.92%,细胞动力科技Cytokinetics Incorporated、KalVista Pharmaceuticals、Centessa Pharmaceuticals跌9.75%-8.1%,美国食品药品管理局主管称加速审批基因疗法将成为常态之际,万基遗传收跌8.04%;Arrowhead Pharmaceuticals则收涨9.10%,Editas Medicine涨24.94%,Ventyx Biosciences涨28.43%领跑。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022905590987ce6435&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022905590987ce6435&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2415517304","title":"嗡嗡声--美国股票走势-Shift4 Payments、Chart Industries、Applied Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2415517304","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2415517304?lang=zh_cn&edition=full","pubTime":"2024-02-29 03:26","pubTimestamp":1709148400,"startTime":"0","endTime":"0","summary":" * Eikon 个股走势搜索字符串:[STXBZ] * The Day Ahead 新闻通讯: * The Morning News Call时事通讯: 2月28日 - 华尔街主要股指周三下滑,因本周晚些时候的通胀数据将影响人们对美国联邦储备委员会何时开始降息的预期。美东时间13:38,道琼斯工业平均指数 下跌0.10%,报38933.98点。标准普尔500指数 下跌0.05%,报5075.46点;纳斯达克综合指数 下跌0.36%,报15976.84点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2415375754","title":"诺瓦瓦克斯医药(NVAX)跌近28% 去年Q4营收不及市场预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2415375754","media":"金吾财讯","top":-1,"share":"https://www.laohu8.com/m/news/2415375754?lang=zh_cn&edition=full","pubTime":"2024-02-28 23:24","pubTimestamp":1709133868,"startTime":"0","endTime":"0","summary":"金吾财讯 | 诺瓦瓦克斯医药(NVAX)震荡走低,截至发稿,跌27.99%,报4.335美元。公司去年第四季度营收2.913亿美元,市场预估3.22亿美元。第四季度每股亏损1.44美元,市场预估每股亏损0.43美元。一年前,Novavax报告每股亏损2.28美元。","market":"us","thumbnail":"https://static.szfiu.com/news/20210625/ZjE4MDdhNTRkYTVhY2QzODgyOWQwYzcxZDQ3NTA3Njg3NjgwMzk=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210625/ZjE4MDdhNTRkYTVhY2QzODgyOWQwYzcxZDQ3NTA3Njg3NjgwMzk=.jpg"],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"273503","is_publish_highlight":false,"gpt_icon":0},{"id":"2415375617","title":"诺瓦瓦克斯医药盘前暴跌逾21% Q4营收不及预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2415375617","media":"新浪财经","top":-1,"share":"https://www.laohu8.com/m/news/2415375617?lang=zh_cn&edition=full","pubTime":"2024-02-28 23:03","pubTimestamp":1709132605,"startTime":"0","endTime":"0","summary":"专题:聚焦美股2023年第四季度财报\n来源:格隆汇\n 诺瓦瓦克斯医药(NVAX.US)美股盘前暴跌逾21%,报4.71美元。消息上,诺瓦瓦克斯医药四季度营收2.913亿美元,市场预估3.22亿美元。四季度每股收益1.44美元,市场预估每股亏损0.43美元。\n\n\n股市回暖,抄底炒股先开户!智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读,尽在新浪财经APP\n\n责任编辑:郭明煜","market":"us","thumbnail":"http://n.sinaimg.cn/spider20240228/152/w526h426/20240228/801d-6db9054504317010272489391e07c2c1.jpg","type":0,"news_type":0,"thumbnails":["http://n.sinaimg.cn/spider20240228/152/w526h426/20240228/801d-6db9054504317010272489391e07c2c1.jpg"],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2024-02-28/doc-inakraum0328569.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2415271613","title":"诺瓦瓦克斯医药股价重挫25.18% 市值跌1.35亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2415271613","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2415271613?lang=zh_cn&edition=full","pubTime":"2024-02-28 22:32","pubTimestamp":1709130722,"startTime":"0","endTime":"0","summary":"北京时间2024年02月28日22时32分,诺瓦瓦克斯医药股票出现波动,股价急速下跌25.18%。截至发稿,该股报4.50美元/股,成交量506.523万股,换手率4.26%,振幅3.32%。诺瓦瓦克斯医药股票所在的生物技术行业中,整体跌幅为0.25%。诺瓦瓦克斯医药公司简介:Novavax Inc是一家开发疫苗的生物技术公司。Novavax与其全资瑞典子公司合作生产候选疫苗,以应对已知和新出现的疾病威胁。Novavax开发面向普通人群所有年龄人口的候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402282232028aebbfc6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402282232028aebbfc6&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2414321432","title":"资料盒-美国和加拿大公司以裁员拉开 2024 年的序幕","url":"https://stock-news.laohu8.com/highlight/detail?id=2414321432","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2414321432?lang=zh_cn&edition=full","pubTime":"2024-02-28 21:46","pubTimestamp":1709128003,"startTime":"0","endTime":"0","summary":" 路透社2月28日 - 2024年伊始,美国和加拿大各行各业的企业纷纷裁员数千人,这表明随着企业争相控制成本,2023年出现的裁员潮可能会持续下去。* 加拿大黑莓 计划在上一季度裁员约200人的基础上,再裁员 。* 资产管理公司贝莱德 将削减约3%的 ,但预计到2024年底将有更多的员工。* 美国连锁百货公司梅西百货 将裁员2350人, ,关闭五家门店。自然资源* 美国矿业公司皮德蒙特锂 在削减成本计划中裁减了 27%的员工。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2414321332","title":"BUZZ-Novavax 因第四季度业绩不佳而下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2414321332","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2414321332?lang=zh_cn&edition=full","pubTime":"2024-02-28 21:30","pubTimestamp":1709127045,"startTime":"0","endTime":"0","summary":" 2月28日 - ** COVID-19 疫苗生产商 Novavax 股价盘前下跌 19.3% 至 4.88 美元** 公司报告 第四季度亏损超过预期,收入不及预期** 该公司称,预计2024年销售额将持平或下降,因为它正努力从规模更大的竞争对手辉瑞 和Moderna 手中夺回市场份额。** 公司第四季度每股亏损1.44美元,营收2.91亿美元** 分析师预计每股亏损45美分,营收约为3.22亿美元--LSEG数据** NVAX预计2024年收入在8亿至10亿美元之间,而LSEG预计为9.696亿美元。** 截至上次收盘,过去12个月股价下跌30.5","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2414325726","title":"诺瓦瓦克斯医药盘中大跌近30%,Q4营收不及预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2414325726","media":"华尔街见闻","top":-1,"share":"https://www.laohu8.com/m/news/2414325726?lang=zh_cn&edition=full","pubTime":"2024-02-28 21:02","pubTimestamp":1709125338,"startTime":"0","endTime":"0","summary":"四季度营收2.913亿美元,市场预估3.22亿美元。 ","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"https://wallstreetcn.com/live/us-stock","is_publish_highlight":false,"gpt_icon":0},{"id":"2414323718","title":"诺维信预计 2024 年销售额持平或下降,目标是扩大 COVID 疫苗的市场份额","url":"https://stock-news.laohu8.com/highlight/detail?id=2414323718","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2414323718?lang=zh_cn&edition=full","pubTime":"2024-02-28 21:00","pubTimestamp":1709125204,"startTime":"0","endTime":"0","summary":" Michael Erman 路透社2月28日 - COVID-19疫苗生产商Novavax 周三表示,该公司预计今年的收入将持平或下降,因为它正努力改善其商业业绩,并从规模大得多的竞争对手辉瑞 和Moderna 手中夺回市场份额。Novavax 表示,预计 2024 年的营收将在 8 亿至 10 亿美元之间,而 2023 年为 9.84 亿美元。雅各布斯说,公司预计今年不会盈利,将继续降低成本。该公司受到生产障碍和监管延误的困扰,无法及时将其疫苗推向市场。因此,Novavax 的股价损失了约 98%,市值不足 7 亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2414061488","title":"诺瓦瓦克斯医药盘中异动 急速拉升5.09%报5.78美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2414061488","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2414061488?lang=zh_cn&edition=full","pubTime":"2024-02-27 22:42","pubTimestamp":1709044967,"startTime":"0","endTime":"0","summary":"北京时间2024年02月27日22时42分,诺瓦瓦克斯医药股票出现波动,股价急速拉升5.09%。截至发稿,该股报5.78美元/股,成交量143.79万股,换手率1.21%,振幅4.47%。诺瓦瓦克斯医药股票所在的生物技术行业中,整体跌幅为0.78%。诺瓦瓦克斯医药公司简介:Novavax Inc是一家开发疫苗的生物技术公司。Novavax与其全资瑞典子公司合作生产候选疫苗,以应对已知和新出现的疾病威胁。Novavax开发面向普通人群所有年龄人口的候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022722424787e739e4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022722424787e739e4&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.novavax.com","stockEarnings":[{"period":"1week","weight":0.0041},{"period":"1month","weight":-0.1182},{"period":"3month","weight":-0.0122},{"period":"6month","weight":-0.3301},{"period":"1year","weight":-0.2127},{"period":"ytd","weight":0.0104}],"compareEarnings":[{"period":"1week","weight":0.0052},{"period":"1month","weight":0.034},{"period":"3month","weight":0.0975},{"period":"6month","weight":0.2238},{"period":"1year","weight":0.3225},{"period":"ytd","weight":0.1007}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Novavax, Inc.是一家新型临床阶段生物制药公司,致力于发现、开发和商业化纳米颗粒重组疫苗和佐剂。公司的疫苗技术平台是根据专有纳米疫苗重组技术开发的,包括病毒样颗粒和蛋白质纳米颗粒候选疫苗。公司的候选疫苗是转基因的三维纳米结构,结合了免疫重要蛋白。公司的疫苗产品针对各种传染病,还有目前在临床开发的针对呼吸道合胞体病毒(RSV)、季节性流感和大流行性流感的产品。此外,CPL生物制剂私人有限公司(CPLB),其合资公司在印度,正积极开发一系列疫苗候选产品,是由诺瓦瓦克斯公司转基因完成的。1987年,诺瓦瓦克斯公司在特拉华州的法律下成立。","yearOnYearQuotes":[{"month":1,"riseRate":0.655172,"avgChangeRate":0.101878},{"month":2,"riseRate":0.586207,"avgChangeRate":0.042134},{"month":3,"riseRate":0.275862,"avgChangeRate":-0.033878},{"month":4,"riseRate":0.464286,"avgChangeRate":0.011589},{"month":5,"riseRate":0.5,"avgChangeRate":0.043165},{"month":6,"riseRate":0.535714,"avgChangeRate":0.107515},{"month":7,"riseRate":0.535714,"avgChangeRate":0.018402},{"month":8,"riseRate":0.535714,"avgChangeRate":0.039529},{"month":9,"riseRate":0.464286,"avgChangeRate":-0.045486},{"month":10,"riseRate":0.321429,"avgChangeRate":0.038967},{"month":11,"riseRate":0.357143,"avgChangeRate":0.005457},{"month":12,"riseRate":0.392857,"avgChangeRate":-0.03691}],"exchange":"NASDAQ","name":"诺瓦瓦克斯医药","nameEN":"Novavax"},"APP":{"userAgent":"claudebot","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.3","shortVersion":"4.22.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"诺瓦瓦克斯医药(NVAX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供诺瓦瓦克斯医药(NVAX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"诺瓦瓦克斯医药,NVAX,诺瓦瓦克斯医药股票,诺瓦瓦克斯医药股票老虎,诺瓦瓦克斯医药股票老虎国际,诺瓦瓦克斯医药行情,诺瓦瓦克斯医药股票行情,诺瓦瓦克斯医药股价,诺瓦瓦克斯医药股市,诺瓦瓦克斯医药股票价格,诺瓦瓦克斯医药股票交易,诺瓦瓦克斯医药股票购买,诺瓦瓦克斯医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"诺瓦瓦克斯医药(NVAX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供诺瓦瓦克斯医药(NVAX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}